203 related articles for article (PubMed ID: 36083294)
1. Biochemistry and Nanomechanical Properties of Human Colon Cells upon Simvastatin, Lovastatin, and Mevastatin Supplementations: Raman Imaging and AFM Studies.
Beton K; Brożek-Płuska B
J Phys Chem B; 2022 Sep; 126(37):7088-7103. PubMed ID: 36083294
[TBL] [Abstract][Full Text] [Related]
2. Mevastatin in colon cancer by spectroscopic and microscopic methods - Raman imaging and AFM studies.
Beton K; Wysocki P; Brozek-Pluska B
Spectrochim Acta A Mol Biomol Spectrosc; 2022 Apr; 270():120726. PubMed ID: 34979441
[TBL] [Abstract][Full Text] [Related]
3. The 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors, simvastatin, lovastatin and mevastatin inhibit proliferation and invasion of melanoma cells.
Glynn SA; O'Sullivan D; Eustace AJ; Clynes M; O'Donovan N
BMC Cancer; 2008 Jan; 8():9. PubMed ID: 18199328
[TBL] [Abstract][Full Text] [Related]
4. A new modality for cholesterol impact tracking in colon cancer development - Raman imaging, fluorescence and AFM studies combined with chemometric analysis.
Beton-Mysur K; Brożek-Płuska B
Anal Methods; 2023 Oct; 15(39):5199-5217. PubMed ID: 37781815
[TBL] [Abstract][Full Text] [Related]
5. Relative lipophilicities, solubilities, and structure-pharmacological considerations of 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors pravastatin, lovastatin, mevastatin, and simvastatin.
Serajuddin AT; Ranadive SA; Mahoney EM
J Pharm Sci; 1991 Sep; 80(9):830-4. PubMed ID: 1800703
[TBL] [Abstract][Full Text] [Related]
6. HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2.
Wächtershäuser A; Akoglu B; Stein J
Carcinogenesis; 2001 Jul; 22(7):1061-7. PubMed ID: 11408350
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of smooth muscle cell calcium mobilization and aortic ring contraction by lactone vastatins.
Escobales N; Crespo MJ; Altieri PI; Furilla RA
J Hypertens; 1996 Jan; 14(1):115-21. PubMed ID: 12013483
[TBL] [Abstract][Full Text] [Related]
8. HMG-CoA reductase inhibitors induce apoptosis in pericytes.
Boucher K; Siegel CS; Sharma P; Hauschka PV; Solomon KR
Microvasc Res; 2006 Mar; 71(2):91-102. PubMed ID: 16427097
[TBL] [Abstract][Full Text] [Related]
9. Comparative impact of systemic delivery of atorvastatin, simvastatin, and lovastatin on bone mineral density of the ovariectomized rats.
Shahrezaee M; Oryan A; Bastami F; Hosseinpour S; Shahrezaee MH; Kamali A
Endocrine; 2018 Apr; 60(1):138-150. PubMed ID: 29372484
[TBL] [Abstract][Full Text] [Related]
10. In vivo and in vitro effects of statins on lymphocytes in patients with Hashimoto's thyroiditis.
Gullu S; Emral R; Bastemir M; Parkes AB; Lazarus JH
Eur J Endocrinol; 2005 Jul; 153(1):41-8. PubMed ID: 15994744
[TBL] [Abstract][Full Text] [Related]
11. Lovastatin and simvastatin--inhibitors of HMG CoA reductase and cholesterol biosynthesis.
Alberts AW
Cardiology; 1990; 77 Suppl 4():14-21. PubMed ID: 2073667
[TBL] [Abstract][Full Text] [Related]
12. Lipophilic but not hydrophilic statins selectively induce cell death in gynaecological cancers expressing high levels of HMGCoA reductase.
Kato S; Smalley S; Sadarangani A; Chen-Lin K; Oliva B; Brañes J; Carvajal J; Gejman R; Owen GI; Cuello M
J Cell Mol Med; 2010 May; 14(5):1180-93. PubMed ID: 19432822
[TBL] [Abstract][Full Text] [Related]
13. Pravastatin inhibited the cholesterol synthesis in human hepatoma cell line Hep G2 less than simvastatin and lovastatin, which is reflected in the upregulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase and squalene synthase.
Cohen LH; van Vliet A; Roodenburg L; Jansen LM; Griffioen M
Biochem Pharmacol; 1993 Jun; 45(11):2203-8. PubMed ID: 8517861
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences.
Lennernäs H; Fager G
Clin Pharmacokinet; 1997 May; 32(5):403-25. PubMed ID: 9160173
[TBL] [Abstract][Full Text] [Related]
15. Differential efficacy of 3-hydroxy-3-methylglutaryl CoA reductase inhibitors on the cell cycle of prostate cancer cells.
Sivaprasad U; Abbas T; Dutta A
Mol Cancer Ther; 2006 Sep; 5(9):2310-6. PubMed ID: 16985065
[TBL] [Abstract][Full Text] [Related]
16. Anti-atherogenic effects of statins: Impact on angiopoietin-2 release from endothelial cells.
Hilbert T; Poth J; Frede S; Klaschik S; Hoeft A; Baumgarten G; Knuefermann P
Biochem Pharmacol; 2013 Nov; 86(10):1452-60. PubMed ID: 24041741
[TBL] [Abstract][Full Text] [Related]
17. Fluvastatin and lovastatin inhibit granulocyte macrophage-colony stimulating factor-stimulated human eosinophil adhesion to inter-cellular adhesion molecule-1 under flow conditions.
Robinson AJ; Kashanin D; O'Dowd F; Fitzgerald K; Williams V; Walsh GM
Clin Exp Allergy; 2009 Dec; 39(12):1866-74. PubMed ID: 19689459
[TBL] [Abstract][Full Text] [Related]
18. Effect of HMG-CoA reductase inhibitors on extracellular matrix expression in human vascular smooth muscle cells.
Riessen R; Axel DI; Fenchel M; Herzog UU; Rossmann H; Karsch KR
Basic Res Cardiol; 1999 Oct; 94(5):322-32. PubMed ID: 10543307
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the effect of the 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors simvastatin, lovastatin and pravastatin on leukaemic and normal bone marrow progenitors.
Newman A; Clutterbuck RD; Powles RL; Catovsky D; Millar JL
Leuk Lymphoma; 1997 Feb; 24(5-6):533-7. PubMed ID: 9086443
[TBL] [Abstract][Full Text] [Related]
20. Statin induces apoptosis and cell growth arrest in prostate cancer cells.
Hoque A; Chen H; Xu XC
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):88-94. PubMed ID: 18199714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
